Browse all practice questions for the Pharmacology IV – Headache Therapeutics Practice Test. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Pharmacology IV – Headache Therapeutics Practice Test course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • Which of the following is an oral CGRP antagonist approved for migraine prevention?
  • What is a common adverse effect of amitriptyline relevant to older patients?
  • What is a key hepatic safety consideration when using gepants?
  • How do CGRP monoclonal antibodies become prescribed in terms of administration?
  • Which CGRP pathway blocking agents are all administered by subcutaneous injection?
  • Which non-oral therapy can be used for acute migraine in an emergency department setting?
  • Which of the following describes the adverse effects of topiramate?
  • In pediatric migraine therapy, how does dosing generally differ from adults?
  • What strategy can reduce tachyphylaxis when using triptans?
  • How is cluster headache diagnosed?
  • Which of the following is a secondary cause to consider in the differential diagnosis of migraine?
  • Which statement about neuromodulation devices is true?
  • Which educational approach helps minimize tachyphylaxis in migraine management?
  • What is used for cluster headache abortive therapy?
  • What is required when considering pediatric dosing for migraines?
  • Which statement about rizatriptan in pediatric use is accurate?
  • Which therapy is commonly used for status migrainosus in a hospital setting?
  • Which of the following lists the adverse drug reactions of candesartan?
  • Which class is a nonspecific serotonin receptor agonist and vasoconstrictor?
  • Which of the following is NOT part of the POUND mnemonic for migraines?
  • Which pair of lifestyle factors is commonly recommended to avoid in migraine management?
  • Which of the following is a precaution or adverse effect associated with divalproex?
  • What is the mechanism of action of ergotamines?
  • What are the adverse drug reactions of rimegepant (Nurtec)?
  • Which statement best describes a common adverse effect of venlafaxine when used for migraine prevention?
  • Which of the following is included in the differential diagnosis for migraine headache?
  • What is the central role of CGRP in migraine pathophysiology?
  • If analgesics and triptans are ineffective or contraindicated, which newer abortive therapies may be used?
  • Which monoclonal antibody is used for migraine prophylaxis?
  • Which propranolol-related concern limits its use in patients with asthma or COPD?
  • Which statement about CGRP monoclonal antibodies is most accurate?
  • Which of the following drug classes was not described as a migraine preventive option in the material?
  • Which statement best describes the pattern of episodic cluster headaches?
  • In patients without pre-existing CAD, the risk of myocardial infarction with triptans is:
  • How can non-pharmacologic therapies improve migraine outcomes?
  • What fundoscopic findings could be abnormal in migraine patients?
  • In elderly patients, which preventive migraine medication is generally favored due to a safer cognitive profile?
  • Which combination is most commonly used for over-the-counter migraine relief?
  • Which statement accurately reflects acute migraine treatment options?
  • According to ICHD-3 criteria, what constitutes migraine without aura?
  • Which option describes CGRP antagonists used for migraine prevention in monoclonal antibody form?
  • Which neuromodulation device is approved for cluster headache?
  • Common ADRs of erenumab include which of the following?
  • Which statement best describes the diagnostic criteria for migraine without aura?
  • Which acute migraine therapy is associated with driving impairment and notable CNS effects?
  • Which statement about adverse effects of CGRP antagonists is NOT true?
  • How do triptans relieve acute migraine symptoms?
  • In patients with pre-existing coronary artery disease, triptans may cause which adverse event?
  • Which of the following describes a common adverse effect of onabotulinumtoxin A for migraine prophylaxis?
  • Which of the following represents other migraine treatment options mentioned beyond standard analgesics?
  • Which is a recommended treatment for mild-moderate tension-type headache?
  • Antiemetics such as metoclopramide or prochlorperazine are used with acute migraine therapy primarily to:
  • What is a goal of long-term migraine management?
  • Why is pediatric safety data important in migraine medications?
  • Typical botox regimen for chronic migraine?
  • Acetaminophen plays what role in acute migraine management?
  • During a migraine attack, CGRP release contributes to which two processes?
  • Which CGRP ligand-targeting monoclonal antibody is used for migraine prevention?
  • What is the typical timeframe to evaluate the effectiveness of a preventive therapy?
  • Concomitant use of ergot derivatives with triptans is contraindicated because of the risk of what?
  • What is a key consideration when prescribing triptans for children?
  • Which statement best describes riboflavin therapy in migraine prevention?
  • The new guidance for migraine prevention encouraged which therapies as first-line?
  • In elderly patients, which medication class should be avoided due to anticholinergic burden?
  • When is dihydroergotamine (DHE) used in acute migraine management?
  • Medication-overuse headache is most commonly associated with overuse of which type of medications?
  • Which of the following is a common adverse drug reaction associated with NSAIDs?
  • Which anti-CGRP monoclonal antibody is marketed as Aimovig?
  • Which factor is essential when dosing triptans in children?
  • Which therapy is primarily preventive, requiring injections at regular intervals?
  • What is the role and typical dose of magnesium in migraine prevention?
  • Sumatriptan in pregnancy is considered:
  • What are the common adverse effects of propranolol when used for migraine prevention?
  • In migraine management, when are ergotamines considered?
  • Which statement best describes the state of approvals for pediatric triptans as per source?
  • Which statement about episodic cluster headaches is true?
  • Which statement about weight-based dosing for pediatric triptans is true?
  • What is one reason that pediatric dosing differs from adult dosing?
  • Neuroimaging is necessary in migraine patients in which circumstances?
  • Which feature is characteristic of tension-type headache symptoms?
  • Dihydroergotamine (DHE) is commonly used for status migrainosus via which routes?
  • What is the main advantage of CGRP monoclonal antibodies for long-term migraine control?
  • Which type of migraine is listed as a contraindication to triptan therapy?
  • What is the primary reason for limiting triptan use to no more than 10 days per month?
  • Which statement about acetaminophen use in pregnancy is correct?
  • Which CGRP monoclonal antibody is ligand-targeting and used for migraine prevention?
  • A common strategy to manage ergotamine-associated nausea is:
  • Which preventive therapy for tension-type headache is a tricyclic antidepressant?
  • Which non-drug option provides rapid relief for acute cluster headache?
  • What is the most severe of the primary headache disorders?
  • Which option is NOT used for migraine prophylaxis?
  • Which of the following is an adverse drug reaction associated with fremanezumab (Ajovy)?
  • Name a commonly used beta-blocker for migraine prevention and one key side effect to monitor.
  • Which of the following describes a sensory feature that can occur with tension-type headaches?
  • Which of the following is an adverse reaction associated with galcanezumab?
  • When combining triptans with SSRIs/SNRIs or MAO inhibitors, what syndrome is of concern?
  • Which statement best explains why triptans are commonly used after OTC products for acute migraine?
  • What is a major safety concern with acetaminophen use?
  • What is a commonly observed consideration when initiating triptans for migraine?
  • Which is a stated goal of acute migraine treatment?
  • According to ICHD-3 criteria, what constitutes migraine with aura?
  • In tension-type headaches, where is the pain most commonly located?
  • Which of the following describes acute migraine treatment options?
  • What is the mechanism of action of onabotulinumtoxin A in migraine prophylaxis?
  • Migraine with aura requires at least how many attacks?
  • Which medications are used as adjuncts for nausea in acute migraine treatment?
  • Which statement about tension-type headache symptoms is true?
  • Which of the following is an adverse effect of ergotamines?
  • For acute migraine that is refractory to initial treatment in the emergency department, which therapy is used?
  • Which statement about DHE administration is correct?
  • Which is NOT listed as a preventive therapy for tension-type headache?
  • What is a newer prescription combination product for migraine that includes a NSAID and a triptan?
  • Which medication is used for moderate-severe tension-type headache in office or emergency settings?
  • Which CGRP ligand-targeting monoclonal antibody is used for migraine prevention?
  • What are the adverse drug reactions of atogepant (Qulipta)?
  • What is the clinical presentation of cluster headache?
  • Over what time frame do typical migraine attacks unfold?
  • Which option correctly identifies a CGRP-targeted prophylaxis therapy?
  • What distinguishes gepants from triptans in terms of vascular effects?
  • Which statement best describes differences between CGRP monoclonal antibodies and onabotulinumtoxinA in prevention?
  • What is first-line therapy for mild to moderate acute episodic migraine?
  • Which of the following best describes dosing differences for pediatric migraine medications?
  • What is the typical maximum daily dose of sumatriptan?
  • What is indomethacin-responsive headache and which diagnosis is classic?
  • Which scenario most clearly requires urgent secondary evaluation and imaging?
  • What is the hallmark of cluster headaches?
  • Which statement about acute migraine treatment includes ergotamines?
  • Which adverse effects are associated with valproate used for migraine prevention?
  • What is the mechanism of action of triptans in migraine treatment?
  • Which statement about diagnostic testing for migraine is true?
  • Which of the following statements is NOT a diagnostic criterion for migraine with aura?
  • In pediatric migraine treatment, what is true about approved therapies and dosing?
  • Before initiating verapamil for cluster headache prophylaxis, which assessment is required?
  • Which of the following is a potential adverse effect of NSAIDs?
  • Which therapy is primarily preventive, requiring injections at regular intervals?
  • When evaluating a patient with suspected migraine, which examination should be performed?
  • Which agent is a CGRP receptor antagonist approved for acute migraine treatment?
  • Which medication is a cluster headache preventive therapy besides verapamil?
  • Which neuromodulation devices are approved for patients aged 12 and older?
  • For cluster headache, an attack lasts how long?
  • In migraine abortive therapy, which category is commonly used and available OTC?
  • Which CGRP mAb is given by IV infusion every 12 weeks?
  • Considering pediatric migraine treatment, the statement 'some triptans have pediatric approvals with weight-based dosing' implies which of the following?
  • Which agent is NOT used for cluster headache prophylaxis?
  • For which patient population is topiramate particularly attractive due to weight loss and migraine reduction?
  • Which of the following describes adverse drug reactions associated with beta blockers used for migraine prophylaxis?
  • Which statement best captures the reason for pediatric-specific safety data?
  • Name two CGRP pathway blocking agents approved for migraine prevention and their general mode of administration.
  • What pattern of pain distribution is described for tension-type headaches?
  • The CGRP receptor antagonists include erenumab, ubrogepant, rimegepant, and atogepant as receptor targets. This category is best described as:
  • Two antidepressants used for migraine prevention and one key adverse effect to monitor.
  • Which class of medications includes propranolol, metoprolol, and nadolol used for migraine prevention?
  • Which statement is part of the diagnostic criteria for tension-type headaches?
  • What is the MOA of calcitonin gene-related peptide antagonists?
  • Which route is typical for gepants when used for acute treatment?
  • Which medication is used for prevention of tension-type headaches?
  • What are the common injection-site reactions for CGRP monoclonal antibodies?
  • Which agent is a CGRP antagonist used for cluster headache prophylaxis?
  • What is a primary goal of acute migraine treatment?
  • Which neurostimulation approach has been explored for cluster headache prophylaxis?
  • Which therapy is listed as abortive for acute cluster headaches?
  • Which vital signs are noted as potentially abnormal in migraine patients?
  • Which agents are gepants used for migraine management?
  • Which of the following are oral CGRP antagonists used for migraine prevention?
  • Which statement best describes the benefit of acetaminophen in migraine management?
  • What is the role and typical dose of riboflavin in migraine prevention?
  • Palpation of which muscles can reveal tender spots in tension headaches?
  • Neuromodulation devices for migraine operate by which mechanism?
  • Which of the following findings could be observed on palpation/auscultation of the head and neck in migraine patients?
  • Which statement about migraine treatment in pregnancy is accurate?
  • Which medication class is not used for migraine treatment?
  • What is the mechanism of action of NSAIDs and acetaminophen in migraine treatment?
  • Which patient-specific characteristics should migraine therapy be tailored to?
  • Which anti-CGRP monoclonal antibody is marketed as Ajovy?
  • What is the primary pharmacologic approach for preventing chronic migraine?
  • Which CGRP monoclonal antibody is a receptor-targeted therapy?
  • Medication-overuse headache (MOH) diagnostic threshold typically involves headache on how many days per month due to overuse of acute medications?
  • Which triptan is cited as having pediatric approval with weight-based dosing?
  • Which medications are commonly considered second-line after NSAIDs for acute episodic migraine?
  • What is a typical maximum daily dose for sumatriptan in acute migraine therapy?
  • Which statement is a criterion for migraine prophylaxis candidacy?
  • Which of the following is a first-line preventive therapy for cluster headache?
  • What safety concern arises when combining triptans with SSRIs/SNRIs or MAO inhibitors?
  • List a major contraindication to triptan use.
  • Which combination of red-flag features most strongly suggests a secondary headache requiring urgent evaluation?
  • Which of the following is a potential example of weight-based dosing concept for pediatric triptans?
  • Which ergotamine preparation is uncommonly prescribed?
  • In acute migraine management, triptans are commonly used in combination with which of the following to enhance efficacy?
  • Which statement best describes the cardiovascular safety profile of CGRP antagonists?
  • What is a typical first-line acute treatment for a healthy adult with moderate migraine without cardiovascular risk?
  • Which of the following describes the adverse drug reactions of eptinezumab (Vyepti)?
  • Basilar migraine has a relative contraindication to the use of which class of drugs?
  • In acute migraine therapy, NSAIDs provide analgesia and anti-inflammatory effects and are often used with triptans; chronic overuse should be avoided due to GI/renal risk.
  • What is lasmiditan's mechanism and a major driving safety caveat?
  • Which therapy is categorized as 'other' for migraine prevention?
  • Which statement best describes the goals of migraine prophylaxis?
  • Which of the following is an anti-seizure medication used for migraine prophylaxis?
  • Which CGRP monoclonal antibody is used for migraine prevention or cluster headache prophylaxis as listed?
  • Which of the following is a beta blocker used for migraine prophylaxis?
  • Are triptans contraindicated with other serotonergic agents due to serotonin syndrome?
  • Neuroimaging studies indicate what in cluster headaches?
  • Which adverse effects are associated with divalproex?
  • Which statement about imaging in cluster headache is true?
  • For chronic migraine, which dosing option reflects onabotulinumtoxin A administration?
  • Which sequence describes the pathophysiology of migraine?
  • Which adverse effect is associated with topiramate?
  • Which condition is a contraindication to triptan therapy?
  • Which therapy is often useful for menstrual-related migraine?
  • OnabotulinumtoxinA is administered by which route for chronic migraine?
  • How do CGRP monoclonal antibodies differ from gepants in clinical use?
  • Which of the following is NOT a component of the POUND mnemonic?
  • Which statement correctly distinguishes gepants from monoclonal antibodies in CGRP-targeted therapy?
  • Which neuromodulation device is also approved for cluster headache?
  • Ergot alkaloids in acute migraine therapy produce what effect and what are key contraindications?
  • Triptans may cause which cardiac effect at therapeutic doses?
  • Which nonpharmacologic therapies are recommended for migraine management?
  • What is one proposed mechanism by which caffeine enhances migraine relief when combined with analgesics?
  • How long do migraine without aura attacks typically last?
  • Which precaution is correct regarding migraine management in pregnancy?
  • Which statement accurately describes menstrual-related migraine management?
  • Which CGRP monoclonal antibody is listed for cluster headache prevention?
  • Which statement best characterizes the tolerability of CGRP monoclonal antibodies?
  • For tension-type headache abortive therapy, which option is NOT listed?
  • What are the four phases of migraine progression?
  • What neuro exam findings could be abnormal in migraine patients?
  • Which agent functions as a gepant?
  • Which product is an ergotamine combination used for migraine?
  • Dihydroergotamine (DHE) is typically administered by which routes for acute migraine management?
  • Which medication is associated with nasopharyngitis and hypersensitivity as adverse effects?
  • What is the trigger for tension-type headache?
  • Which of the following statements is characteristic of cluster headaches?
  • Which of the following is an adverse effect particularly noted with CGRP antagonists in nasal spray form?
  • What is the maximum number of triptan tablets allowed in 24 hours?
  • Which anti-CGRP monoclonal antibody is marketed as Emgality?
  • What is the recommended approach to migraine medications during pregnancy?
  • Which combination is used in Excedrin Migraine?
  • Which of the following is an angiotensin II receptor blocker (ARB) used for migraine prophylaxis?
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy